Management Strategies for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)
Abstract Metabolic dysfunction–associated steatotic liver disease (MASLD) is characterized by hepatic steatosis that is confirmed by imaging or histology in the setting of at least 1 metabolic risk factor in the absence of significant alcohol consumption. …